Marshall Wace, LLP Legend Biotech Corp Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $1.44 Million - $2.06 Million	37,125 New	37,125 $1.85 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $4.3 Million - $7.06 Million	-128,290 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $8.02 Million - $12.5 Million	-258,583 Reduced 66.84%	128,290 $4.66 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $10.1 Million - $14 Million	245,498 Added 173.65%	386,873 $18 Million
Q2 2021 Aug 13, 2021	BUY	$25.8 - $41.09 $3.04 Million - $4.84 Million	117,753 Added 498.49%	141,375 $5.8 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $556,298 - $765,352	23,622 New	23,622 $686,000
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $346,885 - $499,640	-12,614 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$36.1 - $42.56 $455,365 - $536,851	12,614 New	12,614 $537,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.